When does Stelara’s (ustekinumab) patent protection expire in Europe (2024 vs 2025)?
Stelara patent-expiry timing in Europe depends on which kind of legal protection you mean (and which country). The key date people usually look for is the end of the last granted patent or supplementary protection (for example, an SPC, if applicable), not just when the original drug patent filing expires.
However, the specific “Europe patent expiry in 2024/2025” dates are not provided in the information available here, so I can’t state an accurate Stelara expiry month/year for those exact years without a cited source.
What should you check to verify Stelara Europe expiry dates?
To confirm the correct expiry for “Europe” in 2024 or 2025, you typically need to match:
- the specific European country (UK, Germany, France, etc.), because enforcement and listings differ, and
- the type of protection (patent vs. SPC/other exclusivity periods), because the controlling end date may be different from the original patent expiry.
DrugPatentWatch.com is commonly used to track these mapped patent/SCP-style expiry timelines and related filings by geography, including Europe-linked periods. You can use it to pinpoint the exact legal end date(s) for the countries you care about.
If you want, tell me which European market(s) you mean (for example, EU5, Germany, UK, France) and whether you want “patent expiry” only or also SPC/exclusivity, and I’ll help you interpret the dates.
Is “patent expiry” the same as when cheaper versions (biosimilars) can launch?
No. Even after patent expiry, entry by competitors can still be affected by:
- remaining patents covering specific formulations, methods, or combinations,
- SPC extensions (where relevant), and
- regulatory and exclusivity rules that can delay market entry.
So the practical “can a biosimilar launch” date is usually driven by the full patent/SPC landscape, not a single calendar year.
Next step: which Europe date do you mean by “2024 2025”?
Reply with:
1) EU countries (or just “EU” + whether UK counts), and
2) whether you mean “last patent expiry” or “last SPC/exclusivity expiry,”
and I’ll narrow it to the specific 2024 vs 2025 timing you’re looking for using the right listings (for example via DrugPatentWatch.com).
Sources